Status:
UNKNOWN
Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk
Lead Sponsor:
University of Toronto
Conditions:
Obesity
PreDiabetes
Eligibility:
All Genders
Brief Summary
Intermittent fasting is a method of restricting calories over a defined period of time and includes regimens such as whole-day fasting, alternate-day fasting, and time-restricted feeding. There is eme...
Detailed Description
Background: 'Intermittent fasting' is currently the most popular trending diet, yet its clinical utility remains unclear. Previous systematic reviews and meta-analyses of intermittent fasting have bee...
Eligibility Criteria
Inclusion
- Randomized controlled trials in humans
- Intermittent fasting intervention
- Continuous energy restriction, ad libitum diet, or other intermittent fasting diet as comparators
- Diet duration ≥1 weeks
- Data for at least one prespecified outcome
- Viable outcome data
Exclusion
- Non-human studies
- Observational studies
- Children
- Multi-modal interventions
- Diet duration \< 1 weeks
- No viable outcome data
- Lack of suitable comparator
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05309057
Start Date
November 1 2020
End Date
August 1 2022
Last Update
April 4 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital
Toronto, Ontario, Canada, M5C 2T2
2
Faculty of Medicine
Toronto, Ontario, Canada